Pharmacomechanical thrombectomy with Angiojet in acute arterial occlusions: A prospective study among the results and outcomes.

Raphael de Athayde SoaresAna Beatriz Campelo CamposMatheus Veras Viana PortelaCarolina Sabadoto BrienzeGiovana Quarentei Barros BrancherRoberto Sacilotto

Published in: Vascular (2024)

PMT with Angiojet is a safe and effective therapy in patients with ALI. However, patients receiving greater than 150 cycles/s were noted to have higher rates of acute kidney injury and mortality. This is likely reflective of increased thrombus burden and higher rates of hemolysis. Acute kidney injury, greater than 150 cycles/s, and COVID-19 infection were the variables with the strongest association to perioperative mortality.

Keyphrases

acute kidney injury
cardiac surgery
cardiovascular events
risk factors
liver failure
patients undergoing
type diabetes
respiratory failure
cardiovascular disease
acute ischemic stroke
intensive care unit
adipose tissue
mesenchymal stem cells
red blood cell
smoking cessation
replacement therapy